Pds biotech provides business update and reports first quarter 2024 financial results

Provided positive, updated data from phase 2 versatile-002 clinical trial with versamune® hpv in combination with keytruda® in recurrent or metastatic head and neck cancer

PDSB Ratings Summary

PDSB Quant Ranking